Estrogen and bone: Insights from estrogen-resistant, aromatase-deficient, and normal men

Bone

Volumn 43, Issue 3, 2008, Pages 414-417

  Khosla, Sundeep ^a  

^a MAYO CLINIC   (United States)

Author keywords

Bone turnover; Osteoporosis; Sex steroids; Skeletal physiological

Indexed keywords

AROMATASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; RALOXIFENE; TESTOSTERONE;

AGING; BONE DENSITY; BONE GROWTH; BONE MASS; BONE MATURATION; BONE METABOLISM; BONE REMODELING; BONE TURNOVER; CORTICAL BONE; DOSE RESPONSE; DRUG EFFECT; EDITORIAL; FRACTURE; HORMONE BLOOD LEVEL; HUMAN; NONHUMAN; OSTEOLYSIS; OSTEOPENIA; SEX DIFFERENCE; TRABECULAR BONE; VALGUS KNEE;

ADULT; AROMATASE; BONE AND BONES; BONE REMODELING; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; OSTEOGENESIS; PHENOTYPE; SEX FACTORS;

EID: 49149097805     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.05.005     Document Type: Editorial

References (47)

1. Riggs B.L., and Melton L.J. Medical progress series: involutional osteoporosis. N Engl J Med 314 (1986) 1676-1686
2. Smith E.P., Boyd J., Frank G.R., Takahashi H., Cohen R.M., Specker B., et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331 (1994) 1056-1061
3. Carani C., Qin K., Simoni M., Faustini-Fustini M., Serpente S., Boyd J., Korach K.S., and Simpson E.R. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 337 (1997) 91-95
4. Bilezikian J.P., Morishima A., Bell J., and Grumbach M.M. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 339 (1998) 599-603
5. Simpson E.R., Clyne C., Rubin G., Boon W.C., Robertson K., Britt K., et al. Aromatase - a brief overview. Ann Rev Physiol 64 (2002) 93-127
6. Lanfranco F, Zirilli L, Baldi M, Pignatti E, Corneli G, Ghigo E et al., A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement therapy. Bone 2008;(In press).
7. Rochira V., Faustini-Fustini M., Balestrieri A., and Carani C. Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters. J Clin Endocrinol Metab 85 (2000) 1841-1845
8. Bouillon R., Bex M., Vanderschueren D., and Boonen S. Estrogens are essential for male pubertal periosteal bone expansion. J Clin Endocrinol Metab 89 (2004) 6025-6029
9. Slemenda C.W., Longcope C., Zhou L., Hui S.L., Peacock M., and Johnston C. Sex steroids and bone mass in older men: positive associations with serum estrogens and negative associations with androgens. J Clin Invest 100 (1997) 1755-1759.
10. Khosla S., Melton III L.J., Atkinson E.J., O'Fallon W.M., Klee G.G., and Riggs B.L. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 83 (1998) 2266-2274
11. Greendale G.A., Edelstein S., and Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo study. J Bone Miner Res 12 (1997) 1833-1843
12. Center J.R., Nguyen T.V., Sambrook P.N., and Eisman J.A. Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab 84 (1999) 3626-3635
13. Ongphiphadhanakul B., Rajatanavin R., Chanprasertyothin S., Piaseau N., and Chailurkit L. Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males. Clin Endocrinol 49 (1998) 803-809
14. van den Beld A.W., de Jong F.H., Grobbee D.E., Pols H.A.P., and Lamberts S.W.J. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 85 (2000) 3276-3282
15. Amin S., Zhang Y., Sawin C.T., Evans S.R., Hannan M.T., Kiel D.P., et al. Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann Intern Med 133 (2000) 951-963
16. Szulc P., Munoz F., Claustrat B., Garnero P., and Marchand F. Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. J Clin Endocrinol Metab 86 (2001) 192-199
17. Khosla S., Melton L.J., Atkinson E.J., and O'Fallon W.M. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab 86 (2001) 3555-3561
18. Gennari L., Merlotti D., Martini G., Gonnelli S., Franci B., Campagna S., et al. Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. J Clin Endocrinol Metab 88 (2003) 5327-5333
19. Van Pottelbergh I., Goemaere S., and Kaufman J.M. Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age. J Clin Endocrinol Metab 88 (2003) 3075-3081
20. Falahati-Nini A., Riggs B.L., Atkinson E.J., O'Fallon W.M., Eastell R., and Khosla S. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106 (2000) 1553-1560
21. Leder B.Z., LeBlanc K.M., Schoenfeld D.A., Eastell R., and Finkelstein J.S. Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab 88 (2003) 204-210
22. Doran P.M., Riggs B.L., Atkinson E.J., and Khosla S. Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men. J Bone Miner Res 16 (2001) 2118-2125
23. Uebelhart B., Herrmann F., Pavo I., Draper M.W., and Rizzoli R. Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels. J Bone Miner Res 19 (2004) 1518-1524
24. Amin S., Zhang Y., Felson D.T., Sawin C.T., Hannan M.T., Wilson P.W.F., et al. Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. Am J Med 119 (2006) 426-433
25. Khosla S., Melton III L.J., Robb R.A., Camp J.J., Atkinson E.J., Oberg A.L., et al. Relationship of volumetric BMD and structural parameters at different skeletal sites to sex steroid levels in men. J Bone Miner Res 20 (2005) 730-740
26. Genant H.K., Cann C.E., Ettinger B., and Gordan G.S. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 97 (1982) 699-705
27. Lufkin E.G., Wahner H.W., O'Fallon W.M., Hodgson S.F., Kotowicz M.A., Lane A.W., et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 117 (1992) 1-9.
28. Bonewald L.F. Osteocyte messages from a bony tomb. Cell Metab 5 (2007) 410-411
29. Almeida M., Martin-Millan M., Plotkin L.I., Stewart S.A., Roberson P.K., Kousteni S., et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem 282 (2007) 27285-27297
30. Tomkinson A., Reeve J., Shaw R.W., and Noble B.S. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab 82 (1997) 3128-3135
31. Hofbauer L.C., Khosla S., Dunstan C.R., Lacey D.L., Spelsberg T.C., and Riggs B.L. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 140 (1999) 4367-4370
32. Eghbali-Fatourechi G., Khosla S., Sanyal A., Boyle W.J., Lacey D.L., and Riggs B.L. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111 (2003) 1221-1230
33. Roggia C., Gao Y., Cenci S., Weitzmann M.N., Toraldo G., Isaia G., et al. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A 98 (2001) 13960-13965
34. Pfeilschifter J., Koditz R., Pfohl M., and Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 23 (2002) 90-119
35. Weitzmann M.N., and Pacifici R. The role of T lymphocytes in bone metabolism. Immunol Rev 208 (2005) 154-168
36. Srivastava S., Weitzmann M.N., Cenci S., Ross F.P., Adler S., and Pacifici R. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J Clin Invest 104 (1999) 503-513
37. Shevde N.K., Bendixen A.C., Dienger K.M., and Pike J.W. Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc Natl Acad Sci U S A 97 (2000) 7829-7834
38. Nakamura T., Imai Y., Matsumoto T., Sato S., Takeuchi K., Igarashi K., et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of fas ligand in osteoclasts. Cell 130 (2007) 811-823
39. Charatcharoenwitthaya N., Khosla S., Atkinson E.J., McCready L.K., and Riggs B.L. Effect of blockade of TNF-a and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res 22 (2007) 724-729
40. Garnero P., Sornay-Rendu E., Chapuy M., and Delmas P.D. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11 (1996) 337-349
41. Gregorio G.B., Yamamoto M., Ali A.A., Abe E., Roberson P., Manolagas S.C., et al. Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17beta-estradiol. J Clin Invest 107 (2001) 803-812
42. Okazaki R., Inoue D., Shibata M., Saika M., Kido S., Ooka H., et al. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology 143 (2002) 2349-2356
43. Dang Z.C., Van Bezooijen R.L., Karperien M., Papapoulos S.E., and Lowik C.W.G.M. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J Bone Miner Res 17 (2002) 394-405
44. Bord S., Horner A., Beavan S., and Compston J. Estrogen receptors alpha and beta are differentially expressed in developing human bone. J Clin Endocrinol Metab 86 (2001) 2309-2314
45. Sims N.A., Dupont S., Krust A., Clement-Lacroix P., Minet D., Resche-Rigon M., et al. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors beta in bone remodeling in females but not in males. Bone 30 (2002) 18-25
46. Hall J.M., and McDonnell D.P. The estrogen receptor beta-isoform (ER beta) of the human estrogen receptor modulates ER alpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140 (1999) 5566-5578
47. Ritchie L.D., Fung E.B., Halloran B.P., Turnlund J.R., Van Loan M., and Cann C.E. A longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of menses. Am J Clin Nutr 67 (1998) 693-701